-
Gilenya shows promise as an effective therapy for patients with RRMS
Gilenya has shown to be an effective treatment for relapsing-remitting multiple sclerosis in everyday clinical practice, a new study shows. The therapy was successfull to treat even patients switching from Tysabri (natalizumab) treatment.
Read more about it here: “Gilenya Continues to Demonstrate Effectiveness as Therapy for RRMS Patients in Study”
Do you suffer from RRMS? Have you tried Gilenya or Tysabri?
-
0 Replies
Sorry, there were no replies found.
Log in to reply.